Literature DB >> 19128202

Targeting endogenous mu- and delta-opioid receptor systems for the treatment of drug addiction.

T S Shippenberg1, A LeFevour, V I Chefer.   

Abstract

Drug addiction is a chronic, relapsing disorder that is characterized by a compulsion to take drug regardless of the adverse consequences that may ensue. Although the involvement of mesoaccumbal dopamine neurons in the initiation of drug abuse is well-established, neuroadaptations within the limbic cortical- striatopallidal circuit that occur as a consequence of repeated drug use are thought to lead to the behavioral dysregulation that characterizes addiction. Opioid receptors and their endogenous ligands are enriched in brain regions comprising this system and are, thus, strategically located to modulate neurotransmission therein. This article will review data suggesting an important role of mu-opioid receptor (MOPr) and delta opioid receptor (DOPr) systems in mediating the rewarding effects of several classes of abused drugs and that aberrant activity of these opioid systems may not only contribute to the behavioral dysregulation that characterizes addiction but to individual differences in addiction vulnerability.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19128202      PMCID: PMC3730841          DOI: 10.2174/187152708786927813

Source DB:  PubMed          Journal:  CNS Neurol Disord Drug Targets        ISSN: 1871-5273            Impact factor:   4.388


  186 in total

Review 1.  Incentive-sensitization and addiction.

Authors:  T E Robinson; K C Berridge
Journal:  Addiction       Date:  2001-01       Impact factor: 6.526

2.  Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G.

Authors:  Ying Zhang; Danxin Wang; Andrew D Johnson; Audrey C Papp; Wolfgang Sadée
Journal:  J Biol Chem       Date:  2005-07-26       Impact factor: 5.157

3.  Involvement of delta 1 and delta 2 opioid receptor subtypes in the development of physical dependence on morphine in mice.

Authors:  T Suzuki; M Tsuji; T Mori; M Misawa; H Nagase
Journal:  Pharmacol Biochem Behav       Date:  1997 May-Jun       Impact factor: 3.533

Review 4.  A neural substrate of prediction and reward.

Authors:  W Schultz; P Dayan; P R Montague
Journal:  Science       Date:  1997-03-14       Impact factor: 47.728

5.  Effects of single and repeated morphine administration on the prodynorphin, proenkephalin and dopamine D2 receptor gene expression in the mouse brain.

Authors:  J Turchan; W Lasoń; B Budziszewska; B Przewłocka
Journal:  Neuropeptides       Date:  1997-02       Impact factor: 3.286

6.  Role of extracellular dopamine in the initiation and long-term expression of behavioral sensitization to cocaine.

Authors:  C A Heidbreder; A C Thompson; T S Shippenberg
Journal:  J Pharmacol Exp Ther       Date:  1996-08       Impact factor: 4.030

7.  Extinction of cocaine self-administration produces a differential time-related regulation of proenkephalin gene expression in rat brain.

Authors:  J A Crespo; J Manzanares; J M Oliva; J Corchero; T Palomo; E Ambrosio
Journal:  Neuropsychopharmacology       Date:  2001-08       Impact factor: 7.853

8.  Central administration of an opiate antagonist decreases oral ethanol self-administration in rats.

Authors:  C J Heyser; A J Roberts; G Schulteis; G F Koob
Journal:  Alcohol Clin Exp Res       Date:  1999-09       Impact factor: 3.455

9.  Opioid effects on activation of neurons in the medial prefrontal cortex.

Authors:  J L Giacchino; S J Henriksen
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1998-10       Impact factor: 5.067

10.  Time dependent alterations on tyrosine hydroxylase, opioid and cannabinoid CB1 receptor gene expressions after acute ethanol administration in the rat brain.

Authors:  José M Oliva; Sergio Ortiz; Sandra Pérez-Rial; Jorge Manzanares
Journal:  Eur Neuropsychopharmacol       Date:  2007-10-25       Impact factor: 4.600

View more
  28 in total

1.  The prohormone proenkephalin possesses differential conformational features of subdomains revealed by rapid H-D exchange mass spectrometry.

Authors:  Weiya D Lu; Tong Liu; Sheng Li; Virgil L Woods; Vivian Hook
Journal:  Protein Sci       Date:  2012-01-04       Impact factor: 6.725

2.  Influence of δ-opioid receptors in the behavioral effects of nicotine.

Authors:  Fernando Berrendero; Ainhoa Plaza-Zabala; Lola Galeote; África Flores; S Andreea Bura; Brigitte L Kieffer; Rafael Maldonado
Journal:  Neuropsychopharmacology       Date:  2012-06-06       Impact factor: 7.853

Review 3.  Delta opioid receptor analgesia: recent contributions from pharmacology and molecular approaches.

Authors:  Claire Gavériaux-Ruff; Brigitte Lina Kieffer
Journal:  Behav Pharmacol       Date:  2011-09       Impact factor: 2.293

4.  β-endorphin via the delta opioid receptor is a major factor in the incubation of cocaine craving.

Authors:  Yahav Dikshtein; Royi Barnea; Noam Kronfeld; Elad Lax; Ilana Roth-Deri; Alexander Friedman; Iris Gispan; Einat Elharrar; Sarit Levy; Moshe Ben-Tzion; Gal Yadid
Journal:  Neuropsychopharmacology       Date:  2013-06-26       Impact factor: 7.853

5.  MP1104, a mixed kappa-delta opioid receptor agonist has anti-cocaine properties with reduced side-effects in rats.

Authors:  Diana V Atigari; Rajendra Uprety; Gavril W Pasternak; Susruta Majumdar; Bronwyn M Kivell
Journal:  Neuropharmacology       Date:  2019-02-13       Impact factor: 5.250

6.  Disruption of morphine-conditioned place preference by a delta2-opioid receptor antagonist: study of mu-opioid and delta-opioid receptor expression at the synapse.

Authors:  Sophie K Billa; Yan Xia; Jose A Morón
Journal:  Eur J Neurosci       Date:  2010-07-09       Impact factor: 3.386

Review 7.  Molecular Pharmacology of δ-Opioid Receptors.

Authors:  Louis Gendron; Catherine M Cahill; Mark von Zastrow; Peter W Schiller; Graciela Pineyro
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

8.  Resistance exercise decreases heroin self-administration and alters gene expression in the nucleus accumbens of heroin-exposed rats.

Authors:  Mark A Smith; Gaylen E Fronk; Jean M Abel; Ryan T Lacy; Sarah E Bills; Wendy J Lynch
Journal:  Psychopharmacology (Berl)       Date:  2018-02-02       Impact factor: 4.530

Review 9.  The multiple facets of opioid receptor function: implications for addiction.

Authors:  Pierre-Eric Lutz; Brigitte L Kieffer
Journal:  Curr Opin Neurobiol       Date:  2013-02-28       Impact factor: 6.627

Review 10.  Dynorphin, stress, and depression.

Authors:  Allison T Knoll; William A Carlezon
Journal:  Brain Res       Date:  2009-09-24       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.